AEGiS-LT: CONDOM STANDARDS: Panel To Make No Changes Los Angeles TimesImportant note: Information in this article was accurate in 1988. The state of the art may have changed since the publication date.
Click here to return to Los Angeles Times main menu
DonateNow


CONDOM STANDARDS: Panel To Make No Changes

LOS ANGELES TIMES (LT) - THURSDAY June 16, 1988
Allan Parachini; Times Staff Writer


A committee studying revisions in condom manufacturing standards, which are due to expire at the end of this year, has tentatively decided to propose no major changes for the moment but will evaluate a new testing procedure that could lead to more stringent standards, the Times learned Wednesday.

The chairman of the working group refused on Wednesday to discuss details of the deliberations but other members said the decision was reaffirmed Tuesday in a closed meeting in Cincinnati.

Relevance of Lab Tests Debated

The deliberations arose because experts can't agree on the relevance of lab tests as an indicator of how well condoms prevent the spread of the human immunodeficiency virus (HIV), the precursor of AIDS.

The situation presents a potentially significant problem to public health officials trying to determine how effective condoms may be against AIDS and how quality differences among different condom brands can be determined.

The 13-member committee is a subgroup of the American Society for Testing and Materials, a private agency based in Philadelphia that sets standards and specifications for many types of goods, manufacturing processes and engineering services. Final action and any change is not expected until late this year and must be approved by a vote of the society's membership.

Don Marlowe of the FDA's Center for Devices and Radiological Health, and a member of the committee, said the ASTM had arranged a special evaluation by seven laboratories, including one at the U.S. Food and Drug Administration, of a new method of testing condoms by inflating them and measuring the pressures and air volumes required to make them burst.

Committee chairman Mohan Kosamia, of Carter-Wallace, Inc., a New Jersey prophylactic manufacturer, refused comment.

But Marlowe and other committee members said the attempt to add the air-burst test to the standard had been complicated by the growing uncertainty over the relevance of laboratory measurements to the performance of condoms in actual use in sexual situations where spread of HIV is a risk.

The issue had been comparatively insignificant as long as condoms were primarily intended to prevent pregnancy. But with the emergence of AIDS and because the HIV and hepatitis virus are smaller than sperm, "this (the condom) becomes a low-tech product with a high-tech concern" Marlowe said, in terms of its role as a front-line defense against AIDS.

Marlowe and Prakesh Reddy of Schmid Laboratories, another condom maker, said the air-burst test will be evaluated under specially formulated laboratory conditions. Each lab will test condoms from a lot of 3,000 made by a single manufacturer.

Marlowe said the ASTM condom committee, which has been working on a revision of the manufacturing standard for several months, has been aware of work by a federally funded condom research program at UCLA, one of whose researchers is on the committee.

Using an inflation test developed by the International Organization of Standardization (ISO), the UCLA test found that all but one of 31 condom brands tested in the first of three phases of a major new study passed the inflation test while as many as 40% of batches of condoms failed water leakage tests.

In the UCLA study, the results of which were presented at an AIDS conference in Stockholm Wednesday, condoms were able to withstand as much as three times the air pressure required by the experimental ISO standard and all of them exceeded the required air volume. By contrast, 20% of the same condom batches in one test and 40% in another test failed to meet water leakage standards.


Keywords: BIRTH CONTROL DEVICES; HUMAN IMMUNO DEFICIENCY VIRUS; ACQUIRED IMMUNE DEFICIENCY SYNDROME; PRODUCT SAFETY; PUBLIC HEALTHKWDbirthcontroldevices;humanimmunodeficiencyvirus;acquiredimmunedeficiencysyndrome;productsafety;publichealth
880616
LT880610

Copyright © 1988 - Los Angeles Times. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Los Angeles Times, Permissions, Times Mirror Square, Los Angeles, CA 90053.  http://www.latimes.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .